Primary care-based text reminders in colorectal cancer screening

  • Research type

    Research Study

  • Full title

    A randomised controlled trial to test the effectiveness of GP-based text-message reminders to facilitate uptake of colorectal cancer screening in London

  • IRAS ID

    177351

  • Contact name

    Christian von Wagner

  • Contact email

    c.wagner@ucl.ac.uk

  • Sponsor organisation

    University College London

  • Clinicaltrials.gov Identifier

    Z6364106/2015/03/45, UCL Data Protection Registration

  • Duration of Study in the UK

    1 years, 5 months, 31 days

  • Research summary

    Colorectal cancer (CRC, also known as bowel cancer) is the fourth most common cancer and the second leading cause of cancer-related deaths in England. Screening the at risk population for CRC by way of biennial faecal occult blood testing (FOBt) reduces CRC deaths by detecting CRC early, at a time when it is easier to treat. In England, the NHS Bowel Cancer Screening Programme (BCSP) aims to screen 60% of the eligible population every two years; in the previous screening round however (2012-2013), uptake was just below the national target, at 58.49%, and there were major disparities between the capital and the rest of England, with uptake in London 10% below the national average, at 48%. As such, there is an important need for interventions to promote uptake of FOBt in the capital to reduce inequalities in uptake.

    Increasing evidence demonstrates that General Practitioner (GP) endorsement promotes CRC screening uptake and there is a growing interest in the use text-message reminders to increase participation in cancer screening. The present study aims to investigate the effectiveness of a primary care-based text-message reminder to promote CRC screening uptake in London. Patients registered with a participating GP practice will be randomly allocated to receive a text-message from their GP (or not) seven weeks after the kit was mailed to them. The text-message will act as a prompt to return the tests kist if they have not already done so. Uptake in both groups will be measured at 18 weeks and compared for statistically significant differences. This study will be conducted in 180 primary care practices in London and is expected to run for two months (i.e. the sample size [n=3,118] is met).

  • REC name

    East Midlands - Derby Research Ethics Committee

  • REC reference

    15/EM/0159

  • Date of REC Opinion

    1 Apr 2015

  • REC opinion

    Favourable Opinion